vimarsana.com

நியூகேஸில் பல்கலைக்கழகம் ஆசிரிய ஆஃப் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

People who lose sense of smell after Covid may be let down by doctors, says Newcastle study

People who lose sense of smell after Covid may be let down by doctors, says Newcastle study Newcastle University researchers say people who lose these key senses struggle to access treatment from medics For the latest North East news and updates subscribe to the free ChronicleLive newsletter hereInvalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice. Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice People who lose their sense of smell are not getting the help they need from doctors, Newcastle research has claimed.

Smell loss patients are being failed by healthcare professionals, study reveals

Smell loss patients are being failed by healthcare professionals, study reveals People who have lost their sense of smell are being failed by healthcare professionals, new research has revealed. A study by Newcastle University, University of East Anglia and charity Fifth Sense, shows poor levels of understanding and care from GPs and specialists about smell and taste loss in patients. This is an issue that has particularly come to the forefront during the Covid-19 pandemic as many people who have contracted the virus report a loss of taste and smell as their main symptoms. Around one in 10 people who experience smell loss as a result of Covid-19 report that their sense of smell has not returned to normal four weeks after falling ill.

Early Biomarker To Detect Heart Disease in Diabetic Patients

Read Time: New research has shown that people with type 1 diabetes may have features of premature heart disease induced by the condition often before they even get their diagnosis. Early markers for this heart disease could be used to ensure patients get targeted therapies as soon as they are diagnosed with type 1 diabetes to slow down or even halt cardiovascular problems. The findings, published in Stem Cell Research and Therapy, show that tiny pieces of genetic material, called miR-424-5p, increased in early stages of heart disease - these could be targeted to help reduce inflammation in order to compensate for elevated risk.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.